{"altmetric_id":2367917,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[56522],"posts_count":1},"total":{"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4ea3cf058f61000263f","first_seen_on":"2014-05-21T10:35:07+00:00","handles":[],"isbns":[],"issns":["1530-0293"],"issue":"12 Suppl","journal":"Critical Care Medicine","last_mentioned_on":1400580000,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24455791"],"pmid":"24455791","pubdate":"2011-12-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Nursing","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["criticalcare"],"title":"Abstracts of the Society of Critical Care Medicine 41st Critical Care Congress. February 4-8, 2012. Houston, Texas, USA.","type":"article","volume":"39","mendeley_url":"http:\/\/www.mendeley.com\/research\/abstracts-society-critical-care-medicine-41st-critical-care-congress-february-48-2012-houston-texas"},"altmetric_score":{"score":5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5},"context_for_score":{"all":{"total_number_of_other_articles":3785799,"mean":4.9929513758191,"rank":635020,"this_scored_higher_than_pct":82,"this_scored_higher_than":3134447,"rank_type":"exact","sample_size":3785799,"percentile":82},"similar_age_3m":{"total_number_of_other_articles":93495,"mean":7.4108622585407,"rank":17995,"this_scored_higher_than_pct":80,"this_scored_higher_than":75205,"rank_type":"exact","sample_size":93495,"percentile":80},"this_journal":{"total_number_of_other_articles":2960,"mean":5.3900189253126,"rank":795,"this_scored_higher_than_pct":71,"this_scored_higher_than":2118,"rank_type":"exact","sample_size":2960,"percentile":71},"similar_age_this_journal_3m":{"total_number_of_other_articles":106,"mean":10.076457142857,"rank":51,"this_scored_higher_than_pct":50,"this_scored_higher_than":54,"rank_type":"exact","sample_size":106,"percentile":50}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Ph. D. Student":2},"by_discipline":{"Medicine and Dentistry":2}}}},"posts":{"blogs":[{"title":"Piperacillin\/Tazobactam and Risk of Acute Kidney Injury with Vancomycin","url":"http:\/\/academiclifeinem.com\/piperacillin-tazobactam-acute-kidney-injury\/","citation_ids":[2367917,2028201,2289623,2240575],"posted_on":"2014-05-20T10:00:00+00:00","summary":"There are a few reasons why piperacillin\/tazobactam (Zosyn) is not usually my first choice for a broad-spectrum gram-negative agent in the ED. First,&nbsp;at my institution, the Pseudomonas aeruginosa&nbsp;susceptibilities to pip-tazo&nbsp;are&nbsp;lower","author":{"name":"FOAM EM RSSFOAM EM RSS","url":"http:\/\/www.foamem.com\/","description":"Free Open Access Medical Education"}}]}}